NEHI’s research agenda addresses innovation in the health care system:
where it is needed, how it is recognized and validated and how it is adopted.
Learn More
Two NEHI member organizations have launched a multi-cancer early detection (MCED) test pilot project. NEHI applies our research on MCED benefit-risk assessment to this initiative.
This NEHI white paper outlines recommendations for benefit-risk assessment of multi-cancer early detection tests (MCEDs).
This NEHI white paper outlines principles of good communication between health care payers and patients regarding newly approved novel therapies in our health care system.
NEHI has released a report that proposes five principles of communication for shaping exchanges of information among patient groups and U.S. health care payers to enhance and promote trust in payer decision-making on coverage of novel therapies.
NEHI has partnered with Eli Lilly & Company and Avalere Health to release a new report today on advancing health and health care equity in the United States.